• Dec. 2, 2022 7:32 a.m.

FILE - This Oct. 7, 2003 file photo shows a closeup of a human brain affected by Alzheimer’s disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday, Nov. 29, 2022 - and the next question is how much difference that might make in people’s lives. Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better Alzheimer’s treatments. (AP Photo/David Duprey)

Pop-up banner image